BerandaLSTA • NASDAQ
add
Lisata Therapeutics Inc
$2,52
Setelah Jam Perdagangan Normal:(0,00%)0,00
$2,52
Tutup: 16 Okt, 17.47.25 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$2,43
Rentang hari
$2,38 - $2,61
Rentang tahun
$1,87 - $4,20
Kapitalisasi pasar
21,97 jt USD
Volume Rata-Rata
33,78 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 70,00 rb | — |
Biaya operasional | 4,94 jt | -10,59% |
Laba bersih | -4,66 jt | 7,63% |
Margin laba bersih | -6,66 rb | — |
Penghasilan per saham | -0,54 | 11,48% |
EBITDA | -4,82 jt | 11,94% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 21,97 jt | -42,58% |
Total aset | 25,16 jt | -40,90% |
Total liabilitas | 4,38 jt | -4,17% |
Total ekuitas | 20,78 jt | — |
Saham yang beredar | 8,76 jt | — |
Harga terhadap nilai buku | 1,00 | — |
Tingkat pengembalian aset | -44,96% | — |
Tingkat pengembalian modal | -52,89% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -4,66 jt | 7,63% |
Kas dari operasi | -3,96 jt | 25,12% |
Kas dari investasi | 505,00 rb | -95,69% |
Kas dari pembiayaan | 64,00 rb | 100,00% |
Perubahan kas bersih | -3,38 jt | -152,13% |
Arus kas bebas | -2,34 jt | 34,21% |
Tentang
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Didirikan
1980
Kantor pusat
Situs
Karyawan
26
